FOXO TECHNOLOGIES INC. (FOXO) Form 8-K — May 28, 2026
$FOXOForm 8-KItems 1.01, 7.01, 9.01Filed May 28, 2026, 4:45 PM ET0001493152-26-025636Original filing
FOXO Technologies Inc. has entered into a Strategic Technology License Agreement with LongevityFP Technologies, LLC, an entity controlled by founder Jon R. Sabes. The deal grants LongevityFP an exclusive, worldwide license to commercialize FOXO’s epigenetics intellectual property, including two issued patents and proprietary machine learning models.
Key figures
- Option Term
- 10 years
- Royalty Cap
- 1300000
- Equity Stake
- 40%
- Royalty Rate
- 3%
- Dataset Size
- 13,000+ individual epigenetic dataset
- Patent Numbers
- ["11,795,495","11,817,214"]
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.